2 Reasons to Like AMGN (and 1 Not So Much)

Amgen has had an impressive run over the past six months as its shares have beaten the S&P 500 by 5.7%. The stock now trades at $441.95, marking a 16.5% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.